Literature DB >> 7965484

Evolution of Helicobacter pylori positivity in infants born from positive mothers.

U Blecker1, S Lanciers, E Keppens, Y Vandenplas.   

Abstract

To evaluate the mother-child transmission of anti-Helicobacter pylori antibodies, we investigated 562 pregnant women by means of a commercially available second-generation enzyme-linked immunosorbent assay for the detection of anti-H. pylori IgG (Malakit Helicobacter pylori). One hundred twenty-eight of the 562 women had a positive serology for H. pylori. 13C-Urea breath tests were performed in 85 seropositive and in 65 randomly selected seronegative subjects. These breath tests were positive in 82 of the 85 (96.5%) seropositive and in none of the seronegative subjects, reflecting the actual presence of H. pylori in the gastric mucosa of the seropositive women. Cord blood levels for the Malakit Helicobacter pylori were positive in all infants born to seropositive mothers and negative in those born to seronegative mothers. In all infants the previously positive titers had turned negative by the age of 3 months. At the age of 12 to 15 months 13C-urea breath tests were performed in 67 infants born to seropositive mothers. These breath tests were positive in only one infant. By the time the 13C-urea breath tests were performed, the serology had turned negative in all infants with the exception of the one with the positive breath test. We conclude that the IgG antibodies against H. pylori cross the placental barrier and that, despite the present H. pylori infection in the mothers, infants born to these H. pylori-positive women do not appear to have an increased risk of developing a H. pylori-associated gastritis during the first year of life.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7965484     DOI: 10.1097/00005176-199407000-00014

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

Review 1.  Helicobacter pylori infection transmitted sexually via oral-genital contact: a hypothetical model.

Authors:  G D Eslick
Journal:  Sex Transm Infect       Date:  2000-12       Impact factor: 3.519

2.  Helicobacter pylori infection.

Authors:  Yvan Vandenplas
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

3.  Helicobacter pylori: clonal population structure and restricted transmission within families revealed by molecular typing.

Authors:  S R Han; H C Zschausch; H G Meyer; T Schneider; M Loos; S Bhakdi; M J Maeurer
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

4.  Five-year follow-up study of mother-to-child transmission of Helicobacter pylori infection detected by a random amplified polymorphic DNA fingerprinting method.

Authors:  Mutsuko Konno; Nobuhiro Fujii; Shin-ichi Yokota; Kiyoshi Sato; Michiko Takahashi; Kohei Sato; Emi Mino; Toshiro Sugiyama
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 5.  Helicobacter pylori and pregnancy-related disorders.

Authors:  Simona Cardaropoli; Alessandro Rolfo; Tullia Todros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

6.  Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population.

Authors:  Minkyo Song; M Constanza Camargo; Stephanie J Weinstein; Ana F Best; Satu Männistö; Demetrius Albanes; Charles S Rabkin
Journal:  Gastric Cancer       Date:  2018-02-17       Impact factor: 7.370

7.  Increased susceptibility to Helicobacter pylori infection in pregnancy.

Authors:  S Lanciers; B Despinasse; D I Mehta; U Blecker
Journal:  Infect Dis Obstet Gynecol       Date:  1999

Review 8.  Are the view of Helicobacter pylori colonized in the oral cavity an illusion?

Authors:  J K C Yee
Journal:  Exp Mol Med       Date:  2017-11-24       Impact factor: 8.718

9.  A Longitudinal, Population-Level, Big-Data Study of Helicobacter pylori-Related Disease across Western Australia.

Authors:  Michael J Wise; Binit Lamichhane; K Mary Webberley
Journal:  J Clin Med       Date:  2019-11-01       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.